Shi J - Search Results

1

H3K9 lactylation in malignant cells facilitates CD8⁺ T cell dysfunction and poor immunotherapy response.

Wang R, Li C, Cheng Z, Li M, Shi J, Zhang Z, Jin S, Ma H. Wang R, et al. Among authors: shi j. Cell Rep. 2024 Sep 24;43(9):114686. doi: 10.1016/j.celrep.2024.114686. Epub 2024 Aug 30. Cell Rep. 2024. PMID: 39216002 Free article.

2

Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape.

Zhang XY, Shi JB, Jin SF, Wang RJ, Li MY, Zhang ZY, Yang X, Ma HL. Zhang XY, et al. Cancer Commun (Lond). 2024 Jun;44(6):670-694. doi: 10.1002/cac2.12545. Epub 2024 May 12. Cancer Commun (Lond). 2024. PMID: 38734931 Free PMC article.

3

Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.

Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Shi J, et al. Theranostics. 2019 Jan 25;9(4):920-931. doi: 10.7150/thno.30339. eCollection 2019. Theranostics. 2019. PMID: 30867806 Free PMC article.

4

Proteolytic Release of the p75^NTR Intracellular Domain by ADAM10 Promotes Metastasis and Resistance to Anoikis.

Bao X, Shi J, Xie F, Liu Z, Yu J, Chen W, Zhang Z, Xu Q. Bao X, et al. Among authors: shi j. Cancer Res. 2018 May 1;78(9):2262-2276. doi: 10.1158/0008-5472.CAN-17-2789. Epub 2018 Feb 6. Cancer Res. 2018. PMID: 29437707

5

Exosomal miR-626 promotes the malignant behavior of oral cancer cells by targeting NFIB.

Lou C, Shi J, Xu Q. Lou C, et al. Among authors: shi j. Mol Biol Rep. 2022 Jun;49(6):4829-4840. doi: 10.1007/s11033-022-07336-x. Epub 2022 Jun 16. Mol Biol Rep. 2022. PMID: 35711020

6

N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor.

Lou C, Wu K, Shi J, Dai Z, Xu Q. Lou C, et al. Among authors: shi j. J Immunother Cancer. 2022 Sep;10(9):e005061. doi: 10.1136/jitc-2022-005061. J Immunother Cancer. 2022. PMID: 36096526 Free PMC article.

7

Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway.

Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X, Shi J, Li Z, Zhang J, Chen W. Qin X, et al. Among authors: shi j. Theranostics. 2018 Jan 1;8(4):921-940. doi: 10.7150/thno.22182. eCollection 2018. Theranostics. 2018. PMID: 29463991 Free PMC article.

8

Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation.

Shi J, Liu Z, Xu Q. Shi J, et al. Cancer Sci. 2019 Jun;110(6):1909-1920. doi: 10.1111/cas.14012. Epub 2019 Apr 29. Cancer Sci. 2019. PMID: 30945383 Free PMC article.

9

Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.

Qin X, Guo H, Wang X, Zhu X, Yan M, Wang X, Xu Q, Shi J, Lu E, Chen W, Zhang J. Qin X, et al. Among authors: shi j. Genome Biol. 2019 Jan 14;20(1):12. doi: 10.1186/s13059-018-1604-0. Genome Biol. 2019. PMID: 30642385 Free PMC article.

10

Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.

Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X, Shi J, Li Z, Zhang J, Chen W. Qin X, et al. Among authors: shi j. Theranostics. 2022 Jan 21;12(4):1730-1731. doi: 10.7150/thno.69175. eCollection 2022. Theranostics. 2022. PMID: 35198066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,524 results

Search Page

Filters